ICCC - יחס שווי חברה לקצב צמיחת הרווח immucell.com
ImmuCell Corporation (ICCC) utilizes US-based production of biologicals for cattle to eliminate geopolitical risks, although ICCC margins remain dependent on raw material prices and the condition of farms. Comparing the P/E ratio with earnings growth rates demonstrates the valuation trend, where the indicator is held at 0.00. The company is considered a recognized expert in veterinary immunology, developing high-demand health protection products for calves.
פילוחי מדדים ואנליטיקה של חברת ImmuCell Corporation (ICCC)
The PEG ratio relates the current P/E multiple to the company's earnings growth rate. A value below one signals that the asset is undervalued relative to its expansion. By analyzing the correlation between the P/E valuation and growth rates, an investor identifies the potential for rapid price appreciation. For ImmuCell Corporation (ICCC), the dynamics of this metric are critical due to its dependence on agricultural cycles. Fluctuations in meat and milk prices directly impact the business's investment attractiveness.
